Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis
Clinical trial NCT05524155 · UNKNOWN
Trial details
- NCT number
- NCT05524155
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.